# Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older

> **NCT01992094** · PHASE3 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 2680 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** QIVc
- **BIOLOGICAL:** TIV1c
- **BIOLOGICAL:** TIV2c

## Key facts

- **NCT ID:** NCT01992094
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 2680 (ACTUAL)
- **Last updated:** 2015-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01992094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01992094, "Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01992094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*